New Ruthenium-Cyclopentadienyl Complexes Affect Colorectal Cancer Hallmarks Showing High Therapeutic Potential

Colorectal cancer (CRC) is among the most deadly cancers worldwide. Current therapeutic strategies have low success rates and several side effects. This relevant clinical problem requires the discovery of new and more effective therapeutic alternatives. Ruthenium drugs have arisen as one of the most...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Ana Rita Brás, Pedro Fernandes, Tiago Moreira, Julia Morales-Sanfrutos, Eduard Sabidó, Alexandra M. M. Antunes, Andreia Valente, Ana Preto
Format:	Artigo
Jezik:	Inglês
Izdano:	MDPI AG 2023-06-01
Serija:	Pharmaceutics
Teme:	ruthenium-cyclopentadienyl compounds colorectal cancer active targeting passive targeting
Online dostop:	https://www.mdpi.com/1999-4923/15/6/1731
Oznake:	Označite Brez oznak, prvi označite!